MARKET

TEVA

TEVA

Teva Pharm
NYSE
12.89
-0.16
-1.23%
After Hours: 12.89 0 0.00% 19:55 02/23 EST
OPEN
13.09
PREV CLOSE
13.05
HIGH
13.09
LOW
12.61
VOLUME
12.56M
TURNOVER
0
52 WEEK HIGH
13.35
52 WEEK LOW
7.09
MARKET CAP
14.45B
P/E (TTM)
-25.8006
1D
5D
1M
3M
1Y
5Y
iShares Core MSCI Total International Stock ETF Experiences Big Inflow
NASDAQ · 4d ago
TEVA Quantitative Stock Analysis
NASDAQ · 5d ago
Teva Pharma CEO Dismisses Split Speculations Expects Significant Interest For Its API Business Divestiture: Report
Teva Pharmaceutical Industries will not split into two separate entities, CEO says. The company will continue to manage the generics business and its branded drugs. Teva's CEO says the two businesses will complement each other well. Teva Pharmaceutical Industries is a subsidiary of Valeant Pharmaceutical Industries.
Benzinga · 5d ago
Teva Pharmaceuticals Announces Positive Data For Anti-TL1A Asset
NASDAQ · 5d ago
Teva Presents New Data Supporting Safety, Tolerability and Target Engagement of Anti-TL1A (TEV-‘574) Antibody at the 2024 ECCO Annual Meeting
Teva Pharmaceuticals announced positive safety, tolerability, and pharmacokinetic data for its anti-TL1A asset. The drug is a potentially best-in-class human antibody that targets the tumor necrosis factor 1A. The data support continued clinical investigation for moderate-to-severe inflammatory bowel disease. The findings will be presented at the 19th Annual Congress of the European Crohn’s and Colitis Organisation.
Barchart · 5d ago
Corcept Therapeutics: Key Catalysts Ahead
Corcept Therapeutics recently posted solid Q4 results but also faces litigation challenges. The biopharma concern is focused on developing drugs for severe metabolic, oncologic, and neurological disorders. The company just posted fourth-quarter results and 2024 is likely to be an inflection year for Corcept.
Seeking Alpha · 6d ago
Weekly Report: what happened at TEVA last week (0212-0216)?
Weekly Report · 6d ago
Teva Pharmaceutical: I Need To See Top-Line Growth Return Before Starting A Position
Seeking Alpha · 02/15 18:56
More
About TEVA
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Webull offers Teva Pharmaceutical Industries Ltd (ADR) stock information, including NYSE: TEVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TEVA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TEVA stock methods without spending real money on the virtual paper trading platform.